Searched for
RIVASTIGMINE TARTRATE
- Alembic Pharmaceuticals soars on patent settlement case with Novartis
Shares of Alembic Pharma surged by over 4% after the co said it along with Breckenridge Pharma Inc, USA has settled a patent case with Nova...
15 Jun, 2012, 05.26 PM IST
- Indian generic companies may tread Ranbaxy path
Ranbaxy's patent settlement with Pfizer may lead more Indian generic cos to go for out-of-court settlements with their innovator counterpar...
19 Jun, 2008, 01.00 AM IST
- DRL, Novartis smoke peace pipe on Alzheimer's drug
Dr Reddy’s Laboratories (DRL) has entered a settlement agreement with Novartis Pharma to suspend the launch of its generic capsule rivastig...
22 Jan, 2008, 12.00 AM IST
- Sun settles patent row with Novartis
Sun Pharmaceutical Industries has reached an out-of-court settlement with Novartis in the United States with regard to a patent dispute ove...
07 Dec, 2007, 01.50 AM IST
- Sun, Novartis settle Exelon drug dispute
Sun Pharmaceutical has reached an out-of-court settlement with Novartis in the US with regard to a patent dispute over the Swiss drug major...
07 Dec, 2007, 12.12 AM IST
- Stocks to watch on Thursday
Shares of airline companies are likely to see some pressure as the government has asked airlines to come clean on the tax component.
06 Dec, 2007, 09.32 AM IST
- Sun Pharma gets US nod for Novartis' Exelon
Sun Pharma said it has won a 180-day marketing exclusivity for its version of Novartis' $200-million drug Exelon in the US.
26 Oct, 2007, 02.23 AM IST
- DRL gets tentative USFDA nod for Alzheimer's drug
Dr Reddy's Laboratories Ltd has received tentative approval from the USFDA for the drug 'Rivastigmine' in capsule form.
15 Jun, 2006, 02.00 PM IST